Our leadership team brings a unique focus to the complex and ever-changing marketplace to creatively meet the challenges of the 21st century. Our Vision is to become the trusted manufacturer of advanced delivery pharmaceutical products that improve the health and comfort of the customers we serve.

Dr. Jaber Qasem – Vice President & General Manager

Jaber’s expertise is steeped in leadership positions focused on research & development for both brand and generic product development. Before joining the Nesher team in 2012, he held positions of responsibility for the development, approval and launch of new generic products within the pharmaceutical manufacturing industry. Dr. Qasem earned his pharmacy degree from Al-Isra University in Amman, Jordan and Ph.D. in Pharmaceutical Sciences from the University of Kentucky.

Srinivas Gurram - Vice President, Head of Quality and Regulatory Affairs for North America

Joining Zydus in 2006, Srinivas is a highly experienced Pharmaceutical Industry leader with more than 25 years of Pharmaceutical industry experience in terms of Manufacturing, Quality Assurance, Quality Control and Regulatory Affairs. Srinivas successfully guided the organization through more than 25 USFDA audits at its various locations. While being well versed with various aspects of manufacturing and quality, in 2017, Srinivas and his team set an industry record of securing the highest final approvals ever by an organization in generic drug approval space. From October 2018, Srinivas took on a challenge of developing and building an effective quality system at Nesher by deploying Zydus’ corporate quality policies and procedures. Srinivas possesses a Bachelor of Pharmacy degree and Masters in Pharmaceutical Sciences degree with university top rankings. 

Kalpesh Patel –Sr. Director, Finance & IT

Kalpesh’s career in Finance includes the management of numerous finance projects and functions including ERP implementation, IFRS implementation, and the consolidation of group financial statements. Before joining Nesher in 2012, he also established various financial processes and controls. Having worked at a variety of global companies, Kalpesh first earned his Chartered Accountancy degree from New Delhi, India. He remains an active member of the Institute of Chartered Accountants of India.

Scarlett Tumulty – Director, Regulatory Affairs & DEA Compliance

Scarlett has oversight responsibility of Regulatory Affairs and DEA Compliance. With significant pharmaceutical experience, her filing expertise includes numerous ANDAs, NDAs and 505(b)(2) NDAs in multiple dosage forms, including solid oral, liquid, suspensions, semi-solids, and powders.  She has managed post-approval changes, electronic submission publishing, ADE reporting and general Regulatory compliance, as well as ensuring compliance with DEA regulations.  Scarlett earned her Juris Doctorate degree from St. Louis University.  She is a member of the Drug Information Association and Regulatory Affairs Professional Society.